SIAARTI recommendations on the assessment and treatment of chronic cancer pain

Minerva Anestesiologica

Volumn 69, Issue 9, 2003, Pages 697-729

  Ambrosio, F ^a   Paoletti, F ^a   Savoia, G ^a   Amantea, B ^a   Arcuri, E ^a   Avogaro, F ^a   Barbati, A ^a   Beltrutti, D ^a   Branca, L ^a   Camaioni, D ^a   De Conno, F ^a   De Luca, A ^a   Di Massa, A ^a   Evangelista, M ^a   Finco, G ^a   Ischia, S ^a   Mattia, C ^a   Mascaro, A ^a   Mercadante, S ^a   Orlandini, G ^a   Palomba, R ^a   Pasetto, A ^a   Polati, E ^a   Raffaelli, W ^a   Varrassi, G ^a   Visentin, M ^a   Zucco, E ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

CANCER; CANCER PAIN; CLINICAL FEATURE; HUMAN; PAIN ASSESSMENT; REVIEW; WORLD HEALTH ORGANIZATION; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CLASSIFICATION; NEOPLASM; PAIN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

ADULT; AGED; CHILD; CHRONIC DISEASE; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT;

EID: 1542646002     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. nd ed. Geneva: OMS 1996. Italian edition: Quaderni di Sanità Pubblica 1998;21 N104.
2. Piano Sanitario Nazionale 1998-2000. DDL 28-12-98 N 450. Dati sulle morti per grandi gruppi di cause. In: Italia in cifre. Roma: Ed. Istituto Nazionale di Statistica; 1999.
3. Brescia FJ, Adler D, Gray G, Ryan MA, Cimino J, Mamtani R. Hospitalised advanced cancer patients: a profile. J Pain Symptom Manage 1990;5:221-7.
4. Regan JM, Pega P. Neurophysiology of cancer pain. Cancer Control 2000;7:111-9.
5. Mc Cusker J. The terminal period of cancer: definition and descriptive epidemiology. J Chron Dis 1984;37:377-85.
6. Laure F, Colleau S, Brasseur L. Multicentre study of cancer pain and its treatment. BMJ 1995;310:1034-7.
7. Terracini B, Puntoni R. Controllo dei tumori in Italia alla soglia degli anni novanta. Federazione Medica 1990;2: 106-15.
8. Goldberg RJ, Mor V, Wiemann M, Greer DS, Hiris J. Analgesic use in terminal patients: report from the National Hospice Study. J Chronic Dis 1986;39:37-45.
9. Portenoy KA. Pain management in the older cancer patient. Oncology 1992;6:86-98.
10. McGrath PA. Pain in children: nature, assessment, and treatment. New York: The Guilford Press; 1990.
11. Miser AW, Dothage JA, Wesley RA, Miser JS. The prevalence of pain in a pediatric and young adult cancer population. Clin J Pain 1987;29:73-83.
12. Sbanotto A. Dolore e cancro. Ginevra: OMS; 1988.
13. nd ed. Vol 1. Philadelphia: Lea and Febiger; 1990.p.400-60.
14. th World Congress of Pain (Paris 1993). Seattle: IASP Publications; 1999.p.191-2.
15. F. Cleary. Cancer pain management. Cancer Control 2000;7:120-31.
16. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
17. World Health Organization. Cancer pain relief. Geneva: WHO; 1986.
18. A report by the American Society of Anesthesiologists Task Force on pain management, cancer pain section. Practice guidelines for cancer pain management. Anesthesiology 1996;84:1243-57.
19. Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 1999;79:15-20.
20. Mercadante S. Medicina basata sull'evidenza: trattamento del dolore nei pazienti oncologici e validazione della scala analgesica OMS. Minerva Anestesiol 2000;66 Suppl 4:16-20.
21. Ashby MA, Fleming BG, Brooksbank M, Rounsefell B, Runuman WB, Jackson K et al. Description of a mechanistic approach to pain management in advanced cancer: preliminary report. Pain 1992;51:153-61.
22. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain 1999;80:453-62.
23. Bruera E, Macmillan K, Hanson J, MacDonald RN. The Edmonton staging system for cancer pain: preliminary report. Pain 1989;37:203-9.
24. Bruera E, MacDonald S. Audhit methods: The Edmonton Symptom Assessment System. In: Higginson I, editor. Clinical audit in palliative care. Oxford: Radcliffe Medical Press; 1993.p.61-77.
25. Iadarola MJ, Coghill RC. Imaging of pain: recent developments. Curr Opin Anaesthesiol 1999;12:583-9.
26. Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM et al. Dissociating pain from its anticipation in the human brain. Science 1999;284:197-8.
27. Rainville P, Hofgauer RK, Paus T, Duncan GH, Bushnell MC, Price DD. Cerebral mechanisms of hypnotic induction and suggestion. J Cogn Neurosci 1999;11:110-25.
28. Zubieta JK, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry 1999;156:842-8.
29. Lever JR, Ilgin N, Musachio JL, Scheffel U, Finley PA, Flesher JE et al. Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine. Synapse 1998;29:172-82.
30. Caraceni A, Portenoy RK, a working group of the IASP Task Force on Cancer Pain. An international survey of cancer pain characteristics and syndromes. Pain 1999;82:263-74.
31. th ed. New York: Mc Graw Hill; 1996.p.617-58.
32. Vale JA, Meredith TJ. Acute poisoning due to non-steroidal anti-inflammator drugs. Med Toxicol 1986;1: 12-31.
33. Eisenberg E, Berkey CS, Carr DB, Mosteller F, Chalmers TC. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65.
34. Minotti V, de Angelis V, Righetti E, Celani MG, Rossetti R, Lupatelli M et al. Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain. Pain 1998;74:133-7.
35. Minotti V, Betti M, Ciccarese G, Fumi G, Tonato M, Del Favero A. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer. Pharmacotherapy 1998;18:504-8.
36. Pannuti F, Robustelli della Cuna G, Ventafridda V, Strocchi E, Camaggi CM. A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study Group. Tumori 1999;85:96-100.
37. Yalcin S, Gullu IH, Tekuzman G, Davas C, Firat D. A comparison of two nonsteroidal antiinflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain: a randomized crossover study. Am J Clin Oncol 1998;21:185-8.
38. Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB et al. Misoprostol dosage in the prevention of non steroidal anti-inflammatory drug-induced gastric and duodenal ulcer: a comparison of three regimens. Ann Intern Med 1995;123:344-50.
39. Grand S, Meuser T. Weak opioids-an educational substitute for morphine? Curr Opin Anesthesiol 1998;11: 559-65.
40. Budd K. Chronic pain-challenge and response. Drugs 1994;47 Suppl 1:33-8.
41. Edwards JE, McQuay HJ, Moore RA, Colins SL. How to assess harm: lessons from acute postoperative pain. In: Mitchell M, editor. Pain 1999. An update review. Seattle: IASP Press; 1999.p.423-30.
42. Savoia G, Loreto M, Scibelli G. Revisione sistematica dei trials sull'impiego del tramadolo nel trattamento del dolore acuto e cronico. Minerva Anestesiol 2000;66: 713-31.
43. Hanks GW, de Conno F, Cherny N, Hanna M, Kolso E, McQuay HJ et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;84:587-93.
44. Walsh D. Pharmacological management of cancer pain. Semin Oncol 2000;27:45-63.
45. Kloke M, Hoffken K, Olbrich H, Schmidt CG. Antidepressants and anti-convulsants for the treatment of neuropathic pain syndromes in cancer patients. Onkologie 1991;14:40-3.
46. Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 1999;17:441-5.
47. Ventafridda V, Bianchi M, Ripamonti C, Sacerdote P, De Conno F, Zecca E et al. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 1990;43:155-62.
48. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427-32.
49. Kalso E, Rasmyth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 1996;64:293-302.
50. Max MB, Cullane M, Schafer SC, Gracely RH, Walther DJ, Smoller B et al. Amitriptyline releives diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-90.
51. Linee-guida di pratica clinica. Terapia del dolore da cancro. Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research, editor. Ed. ital. Milano: Informedical Consultants; 1999.p.64.
52. Matoba M, Hoka S. Difficulties in cancer pain management. In: Yanagida H, Hanaoka K, Yuge O, editors. Management of pain: a world perspective. Bologna: Monduzzi Editore; 2000.p.37-42.
53. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janian N. Epidural opiates and local anesthetic for the management to cancer pain. Pain 1991;46:271-9.
54. Busins MJ, Bridenbaugh PO. Neural blockade in clinical anesthesia and management of pain. Philadelphia: J.B. Lippincott Williams and Wilkins; 1980.
55. Paterson AHG, Ernst DS, Powles TJ, Ashley S, Mc Closkey EV, Kanis JA. Treatment of skeletal disease in breast cancer with clodronate. Bone 1991;12 Suppl 1: S25-30.
56. Cleeland CS, Gonin R, Hatfield AK, Edmonton JH, Blum RH, Stewart JA et al. Pain and its treatment in outpatient with metastatic cancer: the Eastern co-operative oncology group's outpatient study. N Engl J Med 1994;330:592-6.
57. Finley RS. Bisphosphonates in the treatment of bone metastases. Semin Oncol 2002;29 (1 Suppl 4):132-8.
58. Dougherty PM, Staats PS. Intrathecal drug therapy for chronic pain. Anesthesiology 1999;91:1891-918.
59. Cousins MJ, Suellen MW. Neural blockade and pain management. In: Mitchell M, editor. Pain 1999. An update review. Seattle: IASP Press; 1999.p.289-91.
60. DuPen SL. Epidural techniques for cancer pain management: when, why and how? Curr Rev Pain 1999;3: 183-9.
61. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59;850-6.
62. Ischia S, Finco G, Gottin L, Tannini L, Polati E. EBM e neurolesione. Minerva Anestesiol 2000;66 Suppl. 4:21-6.
63. De Leon-Casasola A, Kent E, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 1993;54:145-51.
64. Gauthier-Lafaye P. Manuale di anestesia locoregionale. Milano: Masson; 1991.
65. Bonezzi C, Orlandini E. Principi di diagnosi e terapia del dolore in oncologia. 2° ed. In: Bonezzi C, Orlandini E, editors. Progressi in oncologia clinica. Pavia: Edimes, 1992.
66. Ischia S, Ischia A, Luzzani A, Toscano D, Steele A. Results up to death in the treatment of persistent cervicothoracic (Pancoast) and thoracic malignant pain by unilateral percutaneous cervical cordotomy. Pain 1985;21:339-55.
67. Moricca G. Chemical hypophysectomy for cancer pain. In: Bonica JJ, editor. Advances in neurology. New York: Raven Press; 1974.p.704-14.
68. Fujita T. Present status of neuroadenolysis of the pituitary gland (NALP) for the relief of terminal cancer pain in Japan. Masui 1987;36:1696-705.
69. Sindou M, Merkens P, Wael M. Microsurgical drezotomy for pain due to spinal cord and/or cauda equina injuries: long-term results in a series of 44 patients. Pain 2001;92:159-71.
70. Hoskin PJ. Radiotherapy in the management of bone pain disease. Clin Orthopaed Res 1995;312:105-19.
71. De Wald RL, Bridwell KH, Prodromas C, Rodta MF. Reconstructive surgery as pallation for metastatic malignancies of the spine. Spine 1985;10:21-6.
72. Harrington KD. Orthopaedic management of metastatic bone disease. St Louis, USA: Mosby Company; 1988.
73. Carey D, Bailie G, Corcoran BA. The evidence base for surgical intervention in the management of cancer pain. In: Hillier R, Finlay I, Welsh J, Miles A, editors. The effective management of cancer pain. London: Aesculapius Medical Press; 2000.p.107-15.